Gemtuzumab Ozogamicin Followed by Unrelated Cord Blood Transplantation With Reduced-intensity Conditioning for a Child With Refractory Acute Promyelocytic Leukemia.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002404
Abstract: There is no established treatment for patients with acute promyelocytic leukemia (APL) refractory to targeted therapies with all-trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). We report here a case of an 8-month-old girl with… read more here.
Keywords: blood transplantation; gemtuzumab ozogamicin; promyelocytic leukemia; unrelated cord ... See more keywords
Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-130849
Abstract: Background .There has been a decrease in the use of unrelated cord blood transplants (UCBT) in the past years: this is probably due to slow hematologic and immune recovery, resulting in a relatively high non… read more here.
Keywords: recovery; unrelated cord; blood; gvhd ... See more keywords
Single nucleotide polymorphisms within HLA region are associated with disease relapse for patients with unrelated cord blood transplantation
Sign Up to like & getrecommendations! Published in 2018 at "PeerJ"
DOI: 10.7717/peerj.5228
Abstract: Disease relapse occurs in unrelated cord blood transplantation (CBT) even when the alleles of human leukocyte antigen (HLA) are fully matched between donor and recipient. This is similar to that observed in other types of… read more here.
Keywords: cord blood; relapse; unrelated cord; transplantation ... See more keywords